COVID-19-Associated Thrombotic Complication: Is It Pulmonary Embolism or In Situ Thrombosis?

Table 1

Clinical features of patients with pulmonary embolism (PE) in situ and PE not in situ.

Variable	PE in situ (n = 51)	PE not in situ (n = 13)	value
	n (%)	n (%)
Sex
Male	32 (64.0)	12 (92.3)	0.086
Female	18 (36.0)	1 (7.7)
Age, mean ± SD	58.70 ± 12.73	55.0 ± 14.38	0.367
Distribution
Central	1 (2.0)	0 (0)	0.794
Peripheral	35 (68.6)	9 (69.2)
Both	15 (29.4)	4 (30.8)
COVID-19
Active COVID-19	41 (80.4)	9 (69.2)	0.457
Post COVID-19	10 (19.6)	4 (30.8)
Superadded bacterial infection	5 (9.8)	0 (0)	0.574
Thrombosis elsewhere	2 (3.9)	2 (15.4)	0.181
Fever	18 (35.3)	4 (30.8)	1.000
Runny nose	2 (3.9)	1 (7.7)	0.500
Cough	21 (41.2)	4 (30.8)	0.544
SOB	35 (68.6)	12 (92.3)	0.157
Headache	1 (2.0)	0 (0)	1.000
Vomiting	1 (2.0)	0 (0)	1.000
Muscle ache/body ache	4 (7.8)	1 (7.7)	1.000
Malaise	2 (3.9)	1 (7.7)	0.500
Lethargy	3 (5.9)	0 (0)	1.000
Pharyngeal discomfort/pain	1 (2.0)	0 (0)	1.000
Chest pain	3 (5.9)	2 (15.4)	0.266
Pleuritic chest pain	1 (2.0)	0 (0)	1.000
Abdominal pain	1 (2.0)	1 (7.7)	0.368
Diarrhea	1 (2.0)	1 (7.7)	0.368
Hemoptysis	1 (2.0)	1 (7.7)	0.368
SYNCOPE	1 (2.0)	0 (0)	1.000
Anorexia	2 (3.9)	0 (0)	1.000
eGFR
Normal	25 (54.3)	8 (61.5)	0.757
Abnormal	21 (45.7)	5 (38.5)
CRP
Normal	6 (20.0)	3 (37.5)	0.363
Abnormal	24 (80.0)	5 (62.5)
D-dimer
Normal	1 (7.1)	2 (33.3)	0.202
Abnormal	13 (92.9)	4 (66.7)
Platelets
Normal	33 (71.7)	10 (83.3)	0.712
Abnormal	13 (28.3)	2 (16.7)
DM	22 (43.1)	3 (23.1)	0.220
IHD	7 (13.7)	0 (0)	0.328
DLP	7 (13.7)	2 (15.4)	1.000
CKD	6 (11.8)	1 (7.7)	1.000
Obesity	2 (3.9)	2 (15.4)	0.181
Cirrhosis	4 (7.8)	0 (0)	0.574
Asthma/ILD/COPD/bronchiectasis	2 (3.9)	1 (7.7)	0.500
Smoking	4 (7.8)	0 (0)	0.574
HTN	16 (31.4)	3 (23.1)	0.739
Cancer	1 (2.0)	0 (0)	1.000
ICU	7 (13.7)	2 (15.4)	1.000
Intubation	5 (9.8)	2 (15.4)	0.623
Expired	18 (35.3)	3 (23.1)	0.518